Precipio, Inc.
Precipio, Inc. (Nasdaq: PRPO) is a healthcare biotechnology company focused on cancer diagnostics, particularly hematologic malignancies. Its pathology services division provides molecular diagnostics, cytogenetics and other specialized testing to physicians, hospitals and laboratories; clinicians send patient blood… From the company’s description.
Over the twelve months to Jun 30, 2026, Precipio, Inc. reported revenue of $27.20M, up 28.0% from a year earlier, and a net loss of $1.22M. Its operating margin was −5.7%, and operations generated $1.10M in cash. In fiscal 2025, it reported revenue of $24.05M, up 29.8% from fiscal 2024, and a net loss of $0.36M.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Precipio, Inc. does
In the company’s own words
Precipio, Inc. (Nasdaq: PRPO) is a healthcare biotechnology company focused on cancer diagnostics, particularly hematologic malignancies. Its pathology services division provides molecular diagnostics, cytogenetics and other specialized testing to physicians, hospitals and laboratories; clinicians send patient blood and biopsy samples to its laboratories for analysis and pathology reports. The products division develops and commercializes diagnostic assays and kits for use by other clinical laboratories. Precipio operates as one reportable segment across these two complementary divisions, using its clinical laboratory operations to support assay development and validation. Its products include HemeScreen, a suite of disease-specific genetic testing panels, and IV-Cell, a cell-culture medium designed to support simultaneous growth of four hematopoietic cell lineages. The company serves oncology practices in more than 20 states and sells products directly or through distributors and laboratory partners. As of March 9, 2026, it had 61 full-time and 10 part-time employees. Its website is http://www.precipiodx.com.
Company details
- Sector
- Health Care
- Industry (SIC)
- Medical Instruments
- Headquarters
- NEW HAVEN, CT
- Fiscal year end
- December
- CIK
- 1043961
- SIC
- 3826
Financial performance, year by year
Fiscal 2011–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Precipio, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Precipio, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Precipio, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Precipio, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Precipio, Inc.'s last four quarterly filings that the numbers alone won't show?”